GSK’s Valtrex Clears FDA Cmte.; Herpes Transmission Endpoints Debated
Executive Summary
Clinical studies for genital herpes drugs intended to demonstrate a reduction in disease transmission should include seroconversion as a primary endpoint, FDA's Antiviral Drugs Advisory Committee agreed May 14